Undisclosed
Pre-clinical- Indications
- Autoimmune diseases
Company intelligence / Profile preview
Yarrow Biotechnology
New York City, New York, USAyarrowbio.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Yarrow Biotechnology is a private biotech company focused on developing antisense oligonucleotide-based and other nucleic acid therapeutics for severe genetically defined disorders, particularly in the areas of autoimmune, cardiometabolic, and CNS diseases. The company leverages proprietary target discovery methods and has an exclusive license to certain ASO technologies from ProQR. As of 2025, its programs are preclinical with undisclosed specific targets or clinical results.
- Therapeutic areas
- CardiovascularImmunologyNeurology
- Modalities
- Antisense oligonucleotides (ASOs)Nucleic acid therapeuticsOther biologic modalities (potentially protein biologics, based on leadership expertise)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ProQR Therapeutics N.V.: Exclusive worldwide license for antisense oligonucleotide technology targeting a non-eye indication; includes milestone payments up to $115 million plus royalties/equity arrangements.
Beyond the preview
Go deeper on Yarrow Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yarrow Biotechnology.